Evidence map›Paper›PMID 42860582›Full record

ArticleAnnals of medicine2026

Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data.

Jiao Wang, Ping Yu, Wenjuan Sun, Yina Wang, Yijun Zhou, Yuxin Liu, Hong Bian, Yuqing Chen, Xuchu Duan, Xu Zhang

Abstract readValidation StudyMulticenter Study
In one paragraph

Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiao WangJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.
Ping YuJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.
Wenjuan SunJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.
Yina WangHemodialysis Center, Jianhu County People's Hospital, Yancheng, China.
Yijun ZhouHemodialysis Center, Affiliated Hospital of Jiangnan University, Jiangnan University, Wuxi, China.
Yuxin LiuJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.
Hong BianJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.
Yuqing ChenDepartment of Pharmacy, Affiliated Hospital of Nantong University, school of Life Science, Affiliated Wuxi Clinical College of Nantong University Wuxi No.2 People's Hospital, Nantong University, Nantong, China.
Xuchu DuanDepartment of Pharmacy, Affiliated Hospital of Nantong University, school of Life Science, Affiliated Wuxi Clinical College of Nantong University Wuxi No.2 People's Hospital, Nantong University, Nantong, China.
Xu ZhangJiangnan University Medical Center, Wuxi No.2 People's Hospital, Wuxi Medical College, Jiangnan university, Wuxi, China.ORCID 0009-0008-2672-6260

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrailty adversely affects survival and quality of life in patients undergoing maintenance hemodialysis (MHD). This study aimed to develop a clinical multimodal model to identify prevalent frailty in MHD patients.

methodsClinical data from 626 MHD patients across four tertiary hospitals were retrospectively collected, including demographics, clinical characteristics, laboratory indicators, and physical function assessments. Frailty was assessed using the FRAIL scale. Patients from Wuxi (

resultsFrailty prevalence was 48.6%. Six predictors were identified: age, grip strength, comorbidities, Charlson comorbidity index (CCI), albumin, and pro-B-type natriuretic peptide (pro-BNP). The extreme gradient boosting (XGBoost) achieved the best external validation performance (AUC=0.917, 95% CI: 0.867-0.967; accuracy=0.847; sensitivity=0.850; specificity=0.844), with good calibration and clinical net benefit. The shapley additive explanations (SHAP) identified pro-BNP as the most influential predictor and revealed nonlinear associations and clinically relevant thresholds.

conclusionThe interpretable XGBoost model effectively identified prevalent frailty in MHD patients, demonstrating strong discrimination, calibration, and clinical applicability, and may support systematic frailty screening and individualized assessment.

Indexed as

FrailtyKidney Failure, ChronicMachine LearningRenal DialysisAgedBoosting Machine Learning AlgorithmsChinaClassification AlgorithmsComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedPredictive Learning ModelsPrevalencefrailtyfrailty classificationmachine learningMaintenance hemodialysis

Identifiers

PMID42860582
PMCPMC13656680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.